Related Experiment Videos
STAT-3 activity in chemically-induced hepatocellular carcinoma
A Sánchez1, P Nagy, S S Thorgeirsson
1Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, MD, Bethesda, USA.
European Journal of Cancer (Oxford, England : 1990)
|September 6, 2003
Summary
Signal transducer and activator of transcription (STAT)-3 is highly active in rat liver tumors. Inhibiting STAT-3 signaling with dexamethasone reduced tumor growth, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Signal transducer and activator of transcription (STAT)-3 is crucial for biological processes and often constitutively active in malignant tumors.
- While STAT-3 is involved in liver regeneration, its role in hepatocellular carcinoma (HCC) remains under-investigated.
Purpose of the Study:
- To investigate STAT-3 activity in chemically-induced rat HCC.
- To explore the effect of dexamethasone on STAT-3 activity and tumor proliferation.
Main Methods:
- Chemically-induced rat hepatocellular carcinoma (HCC) model.
- Electrophoretic mobility shift assay (EMSA) to assess STAT-3 activity.
- Dexamethasone treatment to evaluate its impact on STAT-3 and cell proliferation.
Main Results:
- High STAT-3 activity was detected in rat HCCs.
- Dexamethasone treatment significantly downregulated both STAT-3 activity and tumor cell proliferation.
Conclusions:
- STAT-3 signaling pathway activity is essential for HCC growth.
- STAT-3 represents a potential therapeutic target for hepatocellular carcinoma treatment.